The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling

BACKGROUND: COVID-19 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of disease. 9–20% of hospitalized patients with severe lung disease die from COVID-19 and a substantial number of survivors develop long-COVID. Our objective was to provide co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackermann, Maximilian, Kamp, Jan C., Werlein, Christopher, Walsh, Claire L., Stark, Helge, Prade, Verena, Surabattula, Rambabu, Wagner, Willi L., Disney, Catherine, Bodey, Andrew J., Illig, Thomas, Leeming, Diana J., Karsdal, Morten A., Tzankov, Alexandar, Boor, Peter, Kühnel, Mark P., Länger, Florian P., Verleden, Stijn E., Kvasnicka, Hans M., Kreipe, Hans H., Haverich, Axel, Black, Stephen M., Walch, Axel, Tafforeau, Paul, Lee, Peter D., Hoeper, Marius M., Welte, Tobias, Seeliger, Benjamin, David, Sascha, Schuppan, Detlef, Mentzer, Steven J., Jonigk, Danny D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535314/
https://www.ncbi.nlm.nih.gov/pubmed/36206625
http://dx.doi.org/10.1016/j.ebiom.2022.104296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535314/
https://www.ncbi.nlm.nih.gov/pubmed/36206625
http://dx.doi.org/10.1016/j.ebiom.2022.104296

Ejemplares similares